Results - Announcements
Eiko Lifesciences Ltd share price gained 1.24% to Rs 51.44 after the company's net profit grew slightly 3.31% to Rs 1.56 crore, while revenue from operations slightly gained 5.79% to Rs 17.72 crore in Q3FY26 over Q2FY26.
The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.72 lakh crore, easing 8.53%. It has improved by 3.85% over last one week and edged lower by 5.28% in last one month while the market capitalization of Eiko Lifesciences Ltd has marginally improved by 1.41% and 7.95% in the same period respectively.
Profit before tax (PBT) of Eiko Lifesciences Ltd stood at Rs 2.06 crore in Q3 FY26, surging by 20.47% year-on-year, and gaining 3.00% quarter-on-quarter. EBITDA came in at Rs 2 crore, expanding by 33.11% YoY and rallying 32.24% sequentially.
Total expenses grew marginally by 4.45% to Rs 15.74 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 13.22 crore, slightly declining by 5.16% YoY, while employee benefits expense was at Rs 0.2 crore, remaining flat YoY.
For the TTM ended FY26, revenue from operations witnessed a strong growth of 39.96% to Rs 52.71 crore, while net profit jumped 129.31% to Rs 5.32 crore, compared to previous TTM. EBITDA surged by 132% to Rs 6.47 crore, and PBT surged 132.68% to Rs 7.12 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 2.28 crore in FY26, as against Rs 2.78 crore in FY25.
Eiko Lifesciences Ltd plunged by 10.52% in last one year, underperforming the benchmark BSE Sensex which has slipped by 4.80% during the same period.